Tectonic Therapeutic, Inc. (TECX) — 10-Q Filings
All 10-Q filings from Tectonic Therapeutic, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Tectonic's Losses Widen Amid R&D Surge, $173M Private Placement Boosts Cash
— Nov 6, 2025 Risk: high
Tectonic Therapeutic, Inc. (TECX) reported a net loss of $19.0 million for the three months ended September 30, 2025, and a net loss of $54.9 million for the ni -
Tectonic's Q2 Net Loss Widens to $28.3M Amid R&D Spend
— Aug 7, 2025 Risk: high
Tectonic Therapeutic, Inc. reported no revenue for the three and six months ended June 30, 2025, and June 30, 2024, indicating its pre-commercial stage. The com -
Tectonic Therapeutic Files Q1 2025 10-Q
— May 8, 2025 Risk: medium
Tectonic Therapeutic, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as AVROBIO, Inc., is a biotechnology firm focused on -
Tectonic Therapeutic Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Tectonic Therapeutic, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its busin -
Tectonic Therapeutic Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Tectonic Therapeutic, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as AVROBIO, Inc., is a biotechnology firm focused on -
AVROBIO, Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
AVROBIO, Inc. (TECX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. AVROBIO, Inc. reported cash and cash equivalents of $118.7 million as of March
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX